Skip to main content
. 2021 Apr 26;18:99. doi: 10.1186/s12974-021-02149-4

Table 2.

Influence of treatment with GAT107 on the clinical parameters of EAE

Mean severity Cumulative score Max score Day of onset
Placebo 1.8 ± 0.15 33.8 ± 2.9 2.25 ± 0.14 11.2 ± 0.5
GAT107 0.4 ± 0.12** 8.1 ± 2.4** 0.68 ± 0.18** 14.2 ± 0.6*

*p < 0.05, **p < 0.001